Subscribe to RSS
DOI: 10.1055/s-2008-1078429
N-Substituted Tetronamides as Ambident Nucleophilic Building Blocks for the Synthesis of New 4-Aza-2,3-didehydropodophyllotoxins
Publication History
Publication Date:
16 May 2008 (online)
Abstract
Aza-analogues of podophyllotoxin were synthesized in two steps from N-substituted tetronamides. The acid-mediated benzhydrylation of N-substituted tetronamides with a suitably functionalized benzhydrol quantitatively afforded the cyclization precursors. The target pentacyclic 4-aza-2,3-didehydropodo-phyllotoxins were next obtained via an intramolecular copper-mediated Ullmann-type N-arylation.
Key words
podophyllotoxin - benzhydrylation - copper - N-arylation - tetronamide
-
1a
Sellars JD.Steel PG. Eur. J. Org. Chem. 2007, 3815 -
1b
Ward RS. Nat. Prod. Rep. 1999, 16: 75 -
1c
Ward RS. Nat. Prod. Rep. 1997, 14: 43 -
1d
Ward RS. Nat. Prod. Rep. 1995, 12: 183 -
1e
Ward RS. Nat. Prod. Rep. 1993, 10: 1 - 2
Podwyssotzki V. Arch. Exp. Pathol. Pharmakol. 1880, 13: 29 - 3
King L.Sullivan M. Science 1946, 104: 244 - For reviews, see:
-
4a
Damayanthi Y.Lown JW. Curr. Med. Chem. 1998, 5: 205 -
4b
Zhang Y.Lee K.-H. Chin. Pharm. J. 1994, 46: 319 -
4c
Ramos AC.Pelaéz-Lamamié de Clairac R.Medarde M. Heterocycles 1999, 51: 1443 -
4d
Ward RS. Chem. Soc. Rev. 1982, 75 -
4e
Ward RS. Synthesis 1992, 719 -
4f
Castro MA.Gómez-Zurita MA. Toxicon 2004, 44: 441 -
5a
Cortese F.Bhattacharyya B.Wolff J. J. Biol. Chem. 1977, 252: 1134 -
5b
Andreu JM.Timasheff SN. Biochemistry 1982, 21: 6465 -
5c
Sackett DL. Pharm. Ther. 1993, 59: 163 - 6
Kelly MG.Hartwell JL. J. Nat. Cancer Inst. 1954, 14: 967 - 7
Stähelin H. Eur. J. Cancer 1973, 9: 215 - 8
Stähelin H. Eur. J. Cancer 1970, 6: 303 - 9
Gordaliza M.Castro MA.Miguel del Corral JM.San Feliciano A. Curr. Pharm. Des. 2000, 6: 1811 - 10
MacDonald TL.Lehnert EK.Loper JT.Chow KC.Ross WE. On the Mechanism of Interaction of DNA Topoisomerase II with Chemotherapeutic Agents, In DNA Topoisomerase in CancerPotmesil M.Kohn KW. Oxford University Press; New York: 1991. p.119 - 11
Axelson M, andLarsson O. inventors; PCT Int. Appl., WO 093781. -
12a
Baserga R. Cancer Res. 1995, 55: 249 -
12b
Baserga R. Oncogene 2000, 19: 5574 -
12c
Girnita L.Girnita A.Larsson O. Proc. Natl. Acad. Sci. U.S.A. 2003, 100: 8247 -
12d
Girnita L.Girnita A.Brodin B.Xie Y.Nilsson G.Dricu A.Lundeberg J.Wejde J.Bartolazzi A.Wiman KG.Larsson O. Cancer Res. 2000, 60: 5278 - For recent examples of aza-analogues of podophyllotoxin, see:
-
13a
Magedov IG.Manpadi M.Rozhkova E.Przheval’skii NM.Rogelj S.Shors ST.Steelant WFA.Van slambrouck S.Kornienko A. Bioorg. Med. Chem. Lett. 2007, 17: 1381 -
13b
Magedov IG.Manpadi M.Van Slambrouck S.Steelant WFA.Rozhkova E.Przheval’skii NM.Rogelj S.Kornienko A. J. Med. Chem. 2007, 50: 5183 -
13c
Dorbec M.Florent J.-C.Monneret C.Rager MN.Bertounesque E. Synlett 2006, 591 -
13d
Labruère R.Helissey P.Desbène-Finck S.Giorgi-Renault S. J. Org. Chem 2008, 73: 3642 - 14
Hitotsuyanagi Y.Kobayashi M.Fukuyo M.Takeya K.Itokawa H. Tetrahedron Lett. 1997, 38: 8295 - 15
Hitotsuyanagi Y.Fukuyo M.Tsuda K.Kobayashi M.Ozeki A.Itokawa H.Takeya K. Bioorg. Med. Chem. Lett. 2000, 10: 315 -
16a
Tratrat C.Giorgi-Renault S.Husson H.-P. Org. Lett. 2002, 4: 3187 -
16b
Giorgi-Renault S. Ann. Pharm. Fr. 2005, 63: 63 -
16c
Husson H.-P,Giorgi-Renault S,Tratrat C,Atassi G,Pierre A,Renard P, andPfeiffer B. inventors; Eur. Patent, EP1103554. - 17
Bisaro F.Prestat G.Vitale M.Poli G. Synlett 2002, 1823 - 18
Mingoia F.Vitale M.Madec D.Prestat G.Poli G. Tetrahedron Lett. 2008, 49: 760 - 19
Poli G.Giambastiani G. J. Org. Chem. 2002, 67: 9456 - For previous use of N-benzyl tetronamides as building block, see:
-
20a
Sydorenko N.Hsung RP.Darwish OS.Hahn JM.Liu J. J. Org. Chem. 2004, 69: 6732 -
20b
McLaughlin MJ.Hsung RP.Cole KC.Hahn JM.Wang J. Org. Lett. 2002, 4: 2017 -
20c See also
Pévet I.Meyer C.Cossy J. Synlett 2003, 663 - 21
Momose T.Toyooka N.Nishi T.Takeuchi Y. Heterocycles 1988, 27: 1907 - 22
Jung ME.Lam PYS.Mansuri MM.Speltz LM. J. Org. Chem. 1985, 50: 1087 -
24a
Hartwig JF. Angew. Chem. Int. Ed. 1998, 37: 2046 -
24b
Wolfe JP.Wagaw S.Marcoux JF.Buchwald SL. Acc. Chem. Res. 1998, 31: 805 -
24c
Hartwig JF. Acc. Chem. Res. 1998, 31: 852 -
24d
Yang BH.Buchwald SL. J. Organomet. Chem. 1999, 576: 125 -
24e
Hartwig JF. In Handbook of Organopalladium Chemistry for Organic Synthesis Vol. 1:Negishi EI. Wiley-Interscience; New York: 2002. p.1051 -
24f
Muci AR.Buchwald SL. Topics in Current Chemistry Vol. 219: Springer-Verlag; Germany: 2002. Chap. 5. -
25a
Kunz K.Scholz U.Ganzer D. Synlett 2003, 2428 -
25b
Ley SV.Thomas AW. Angew. Chem. Int. Ed. 2003, 42: 5400 -
25c
Beletskaya IP.Cheprakov AV. Coord. Chem. Rev. 2004, 248: 2337 - 26
Okano K.Tokuyama H.Fukuyama T. Org. Lett. 2003, 5: 4987
References and Notes
Present address: Istituto per lo Studio dei Materiali Nanostrutturati, CNR, Via Ugo La Malfa 153, 90146 Palermo, Italy
23Representative Experimental Procedure for Benzhydrylation Reaction: To a stirred solution of benzhydrol 6 (437 mg, 1.1 mmol, 1.1 equiv) and enamine 4a (189 mg, 1 mmol) in anhyd CH2Cl2 (10 mL) under a N2 atmosphere at r.t. was added BF3×OEt2 (0.380 mL, 3 equiv). The mixture was stirred for 2 h before a sat. aq NaHCO3 solution (10 mL) was added. The aqueous layer was extracted with Et2O (3 × 10 mL). The organic layers were washed with brine (5 mL), dried over MgSO4 and concentrated under reduced pressure. The crude material was purified by flash chromatography (cyclohexane-EtOAc, 7:3) to afford the alkylated product 8a as a white foam (455 mg, 80% yield). 1H NMR (400 MHz, CDCl3): δ = 3.74 (s, 6 H), 3.80 (s, 3 H), 4.05-4.16 (m, 2 H), 4.64-4.79 (d, AB system, J = 15.4 Hz, 2 H), 5.38 (s, 1 H), 5.93 (d, J = 1.3 Hz, 1 H), 6.00 (d, J = 1.3 Hz, 1 H), 6.35 (s, 2 H), 6.65 (s, 1 H), 6.95 (d, J = 7.6 Hz, 2 H), 7.07 (s, 1 H), 7.32-7.28 (m, 3 H). 13C NMR (100 MHz, CDCl3): δ = 46.0, 47.8, 56.3, 61.0, 65.3, 95.8, 101.9, 105.7, 109.6, 113.5, 115.8, 126.6, 128.3, 129.1, 133.3, 136.0, 136.7, 137.1, 147.4, 147.5, 153.7, 163.3, 174.5. IR (neat): 3375, 2930, 2870, 1730, 1625, 1585, 1500, 1475, 1415, 1230, 1120, 1035 cm-1. HRMS (CI): m/z calcd for C28H26O7N79BrNa: 590.07849 and C28H26O7N81BrNa: 592.07692; found: 590.07755 and 592.07560.
27Representative Experimental Procedure for Intramolecular Copper-Mediated N-Arylation Reaction: To a solution of cyclization precursor 8a (217 mg, 0.38 mmol) in anhyd DMF (4 mL) at r.t. were added CuI (87 mg, 0.46 mmol, 1.2 equiv) and Cs2CO3 (311 mg, 0.96 mmol, 2.5 equiv). The resulting mixture was stirred at 90 °C for 16 h. A sat. aq NH4Cl solution (5 mL) was added and the aqueous phase was extracted with CH2Cl2 (3 × 10 mL). The collected organic phases were washed with aq NH3-NH4Cl solution (1:1, 10 mL), brine (3 × 5 mL), and dried over MgSO4. The solvent was removed under reduced pressure. The crude product was purified by flash chromatography (cyclohexane-EtOAc, 7:3) to afford aza-analogue 9a as a yellow foam (185 mg, quantitative yield). 1H NMR (400 MHz, CDCl3): δ = 3.82 (s, 9 H), 4.75-4.89 (m, 4 H), 5.08 (s, 1 H), 5.89 (d, J = 1.2 Hz, 1 H), 5.91 (d, J = 1.2 Hz, 1 H), 6.45 (s, 1 H), 6.46 (s, 2 H), 6.59 (s, 1 H), 7.24-7.38 (m, 5 H). 1H NMR (400 MHz, DMSO-d 6): δ = 3.61 (s, 3 H), 3.73 (s, 6 H), 4.94 (s, 1 H), 4.96 (d, AB system, J = 17.4 Hz, 2 H), 5.13 (d, AB system, J = 15.9 Hz, 2 H), 5.87 (d, J = 0.8 Hz, 1 H), 5.95 (d, J = 0.8 Hz, 1 H), 6.53 (s, 2 H), 6.72 (s, 1 H), 6.77 (s, 1 H), 7.29-7.40 (m, 5 H). 13C NMR (100 MHz, DMSO-d 6): δ = 39.8, 48.9, 55.8, 59.9, 65.6, 95.5, 96.7, 101.4, 104.6, 110.0, 119.1, 126.5, 127.6, 128.9, 131.1, 136.0, 136.5, 142.6, 143.5, 146.7, 152.9, 159.9, 172.2. IR (neat): 2935, 2845, 1730, 1645, 1615, 1590, 1505, 1475, 1240, 1190, 1125, 1040 cm-1. HRMS (CI): m/z calcd for C28H25O7NNa: 510.15232; found: 510.15154.
28The cyclization of enolic precursors such as 7 to give 4-oxa-2,3-didehydropodophyllotoxin analogues will be the object of a separate study and will be reported elsewhere.